Clinical Trials Browser

Unknown × Recurrence × Bevacizumab × Clear all

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

Recurrence, Triple Negative Breast Neoplasms

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Recurrence